The hemophagocytic lymphohistiocytosis market is expected to increase due to the launch of emerging therapies, such as plonmarlimab (TJ Biopharma), ELA026 (Electra Therapeutics), MAS825 (Novartis) ...
In a new study, researchers examined herbal supplements with immune-activating properties that could trigger or worsen ...
Subcutaneous anifrolumab (Saphnelo) added to standard therapy significantly improves treatment outcomes in patients with ...
USA: Researchers have reported that low vitamin D levels are strongly linked to a higher risk of death and cardiovascular ...
The burden of autoimmune diseases is steadily rising, particularly among women, and the winter months — compounded by high ...
The prevalence of autoimmune diseases is increasing, especially in women, and the ongoing winter season, along with high ...
Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback